UTI Healthcare Fund - Growth - Direct Plan

  • Previous Nav

  • Net Change on 04-10-2022

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Direct Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The primary objective of the scheme is to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector. However, there can be no assurance or guarantee that the investment objective of the scheme would be achieved.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
UTI Healthcare Fund - Direct Plan - Growth Option 3.12 7.97 -10.44 26.59 14.16 13.66
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A
S&P BSE Health Care - TRI 4.32 9.54 -10.40 25.34 12.16 13.83

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
UTI Healthcare Fund - Direct Plan - Growth Option Jan 01, 2013 -10.44 26.59 14.16 1.40 713.11
Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option - Growth Jan 01, 2013 -7.08 28.01 18.29 1.00 4,587.75
SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH Jan 01, 2013 -5.63 28.26 13.80 1.06 1,675.44
Tata India Pharma & Healthcare Fund-Direct Plan-Growth Dec 28, 2015 -5.02 26.20 17.19 0.99 519.10

Fund Holdings as on 31-August-2022

  • EQ - SUN PHARMACEUTICALS INDUSTRIES

  • EQ - DR REDDYS LABORATORIES LTD.

  • EQ - CIPLA LTD.

  • EQ - APOLLO HOSPITALS ENTERPRISE LT

  • EQ - FORTIS HEALTHCARE LTD.

  • EQ - AUROBINDO PHARMA LTD.

  • EQ - DIVIS LABORATORIES LTD.

  • EQ - AJANTA PHARMA LTD.

  • EQ - ERIS LIFESCIENCES LTD

  • EQ - IPCA LABORATORIES LTD.

  • EQ - ZYDUS LIFESCIENCES LTD

  • EQ - KRISHNA INSTITUTE OF MEDI SCIE

  • EQ - TORRENT PHARMACEUTICALS LTD.

  • EQ - BIOCON LTD.

  • EQ - SUVEN PHARMACEUTICALS LTD

  • EQ - GLAND PHARMA LTD.

  • EQ - ALKEM LABORATORIES LTD

  • EQ - LUPIN LTD.

  • EQ - ABBOTT INDIA LTD.

  • EQ - POLY MEDICURE LTD

  • EQ - J.B.CHEMICALS & PHARMACEUTICAL

  • NET CURRENT ASSETS

  • EQ - RAINBOW CHILDRENS MEDICARE LTD

  • EQ - PROCTOR & GAMBLE HEALTH LTD

  • EQ - ALEMBIC PHARMACEUTICALS

  • EQ - PFIZER LIMITED

  • EQ - AMI ORGANICS LTD

  • EQ - METROPOLIS HEALTHCARE LTD

  • EQ - SEQUENT SCIENTIFIC LTD

  • EQ - INDOCO REMEDIES LTD.

  • EQ - NARAYANA HRUDAYALAYA LTD

  • EQ - WINDLAS BIOTEC LTD

  • INDIAN BANK STD - MARGIN

  • T BILL RESERVE BANK OF INDIA

  • CLEARING CORPORATION OF INDIA LTD. STD - MARGIN

View More
  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Medical Equipment/Supplies/Accessories

  • Miscellaneous

View More

Fund Manager

  • Cash

  • Deposits

  • Equity

  • SOV

View More

About UTI Healthcare Fund

Scheme Analysis

UTI Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to UTI Mutual Fund. It was launched on 01-Jan-2013 and currently has an AUM of ₹713.11 crore. UTI Healthcare Fund is benchmarked against NIFTY 50 - TRI as primary index and S&P BSE Health Care - TRI as secondary index.

The NAV of UTI Healthcare Fund ended up ₹1.47(0.88%)yesterday to ₹167.7863.

Among its top 3 holdings the fund has exposure to EQ - SUN PHARMACEUTICALS INDUSTRIES, and

The UTI Healthcare Fund is managed by V. Srivatsa and Kamal Gada.

Fund House Contact

UTI Towers, Gn Block, Bandra Kurla Complex, Bandra (East) Mumbai - 400 051

+91 (22) 66786666
service@uti.co.in
+91 (22) 66786503,56786578
www.utimf.com